IP Library Granted Patent US 9,070,006
Granted Patent B2
US 9,070,006 · App. 11/957,084 · Granted Jun 30, 2015

Method and system for processing an image of a biological specimen

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,070,006
App. No.
11/957,084
Granted
Jun 30, 2015
Kind
B2
Abstract

Components, e.g., background, cytoplasm, nucleus and nucleolus, of a biological specimen are identified using multi-wavelength analysis. Specimen components, such as nucleoli, are selected, and a determination is made whether cells having nucleoli are cancer cells or regular repair cells based on one or more physical characteristics of the identified component. The physical characteristics can be one or more of a shape, size, texture and gray value.

Claims (16)

1. A method of processing an image of a biological specimen, the specimen having a plurality of cells, the method comprising:

identifying nucleoli of the cells of the biological specimen in the image based on spectral characteristics of the nucleoli;

and

using a processor to evaluate one or more physical characteristics of the nucleoli in order to determine whether cells having the nucleoli have a likelihood of being cancerous or non-cancerous.

2. The method of claim 1 , wherein the nucleoli of the cells of the specimen are identified using one or more light wavelengths in a range from about 400 nm to about 720 nm.

3. The method of claim 1 , wherein identifying the nucleoli of the cells of the specimen comprises classifying a pixel of the image as a nucleolus of a cell of the biological specimen based on spectral characteristics of the pixel.

4. The method of claim 1 , further comprising determining whether cells corresponding to the nucleoli are cancer cells or normal repair cells.

5. The method of claim 1 , wherein the determination of whether cells having the nucleoli have a likelihood of being cancerous or non-cancerous is based on a shape of the nucleoli.

6. The method of claim 1 , wherein the determination of whether cells having the nucleoli have a likelihood of being cancerous or non-cancerous is based on a texture of the nucleoli.

7. The method of claim 1 , wherein the determination of whether cells having the nucleoli have a likelihood of being cancerous or non-cancerous is based on a size of the nucleoli.

8. The method of claim 1 , wherein the determination of whether cells having the nucleoli have a likelihood of being cancerous or non-cancerous is based on a transmittance or gray value of the nucleoli or of an image pixel of the nucleoli.

9. A system for processing an image of a biological specimen having a plurality of cells, comprising:

an imager having a processor configured to identify nucleoli of the cells of the biological specimen in the image based on spectral characteristics of the nucleoli, and evaluate one or more physical characteristics of the nucleoli in order to determine whether cells in the image having the nucleoli are cancerous or non-cancerous.

10. The system of claim 9 , wherein the nucleoli of the cells of the specimen are identified using one or more light wavelengths in a range from about 400 nm to about 720 nm, the system comprising a source or sources of the one or more light wavelengths.

11. The system of claim 9 , wherein the processor identifies the nucleoli of the cells of the specimen based on classifying a pixel of the image as a nucleolus of a cell of the biological specimen based on spectral characteristics of the pixel.

12. The system of claim 9 , the processor further configured to determine whether cells corresponding to the nucleoli are cancer cells or normal repair cells based on one or more of a shape, a texture, a size and a transmittance of the nucleoli.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0879 →
FIRST SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded May 7, 2008
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 020915/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2008
From: WONG, KAM LIN; ZAHNISER, DAVID; MUI, KATHY; LINDER, JIM; SHEETS, ELLEN
To: CYTYC CORPORATION
Reel/Frame 020560/0667 →